These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35280915)

  • 1. Cardiovascular Risks and Risk Stratification in Inflammatory Joint Diseases: A Cross-Sectional Study.
    Yagensky V; Schirmer M
    Front Med (Lausanne); 2022; 9():786776. PubMed ID: 35280915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update.
    Agca R; Heslinga SC; Rollefstad S; Heslinga M; McInnes IB; Peters MJ; Kvien TK; Dougados M; Radner H; Atzeni F; Primdahl J; Södergren A; Wallberg Jonsson S; van Rompay J; Zabalan C; Pedersen TR; Jacobsson L; de Vlam K; Gonzalez-Gay MA; Semb AG; Kitas GD; Smulders YM; Szekanecz Z; Sattar N; Symmons DP; Nurmohamed MT
    Ann Rheum Dis; 2017 Jan; 76(1):17-28. PubMed ID: 27697765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atherosclerotic cardiovascular disease in patients with chronic inflammatory joint disorders.
    Agca R; Heslinga SC; van Halm VP; Nurmohamed MT
    Heart; 2016 May; 102(10):790-5. PubMed ID: 26888573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-steroidal anti-inflammatory drugs and risk of pulmonary embolism in patients with inflammatory joint disease-results from the nationwide Norwegian Cardio-rheuma registry.
    Ikdahl E; Rollefstad S; Kazemi A; Provan SA; Larsen TL; Semb AG
    Eur Heart J Cardiovasc Pharmacother; 2024 Jan; 10(1):27-34. PubMed ID: 37881093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: Baseline data of the CARMA Project.
    Castañeda S; Martín-Martínez MA; González-Juanatey C; Llorca J; García-Yébenes MJ; Pérez-Vicente S; Sánchez-Costa JT; Díaz-Gonzalez F; González-Gay MA;
    Semin Arthritis Rheum; 2015 Jun; 44(6):618-26. PubMed ID: 26058345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unmet needs in the management of cardiovascular risk in inflammatory joint diseases.
    Castañeda S; Vicente-Rabaneda EF; García-Castañeda N; Prieto-Peña D; Dessein PH; González-Gay MA
    Expert Rev Clin Immunol; 2020 Jan; 16(1):23-36. PubMed ID: 31779487
    [No Abstract]   [Full Text] [Related]  

  • 7. Sex and Cardiovascular Involvement in Inflammatory Joint Diseases.
    Castañeda S; González-Juanatey C; González-Gay MA
    Clin Rev Allergy Immunol; 2019 Jun; 56(3):278-292. PubMed ID: 28852999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subclinical impairment of myocardial and endothelial functionality in very early psoriatic and rheumatoid arthritis patients: Association with vitamin D and inflammation.
    Lo Gullo A; Rodríguez-Carrio J; Aragona CO; Dattilo G; Zito C; Suárez A; Loddo S; Atteritano M; Saitta A; Mandraffino G
    Atherosclerosis; 2018 Apr; 271():214-222. PubMed ID: 29524864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular disease risk profiles in inflammatory joint disease entities.
    Wibetoe G; Ikdahl E; Rollefstad S; Olsen IC; Bergsmark K; Kvien TK; Salberg A; Soldal DM; Bakland G; Lexberg Å; Fevang BT; Gulseth HC; Haugeberg G; Semb AG
    Arthritis Res Ther; 2017 Jul; 19(1):153. PubMed ID: 28673314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guideline recommended treatment to targets of cardiovascular risk is inadequate in patients with inflammatory joint diseases.
    Ikdahl E; Wibetoe G; Rollefstad S; Salberg A; Bergsmark K; Kvien TK; Olsen IC; Soldal DM; Bakland G; Lexberg Å; Fevang BTS; Gulseth HC; Haugeberg G; Semb AG
    Int J Cardiol; 2019 Jan; 274():311-318. PubMed ID: 30007486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment to lipid targets in patients with inflammatory joint diseases in a preventive cardio-rheuma clinic.
    Rollefstad S; Kvien TK; Holme I; Eirheim AS; Pedersen TR; Semb AG
    Ann Rheum Dis; 2013 Dec; 72(12):1968-74. PubMed ID: 23264359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smoking cessation intervention for reducing disease activity in chronic autoimmune inflammatory joint diseases.
    Roelsgaard IK; Esbensen BA; Østergaard M; Rollefstad S; Semb AG; Christensen R; Thomsen T
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD012958. PubMed ID: 31476270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of cardiovascular disease risk assessments in rheumatology outpatient clinics: experiences from the nationwide NOCAR project.
    Ikdahl E; Rollefstad S; Wibetoe G; Salberg A; Krøll F; Bergsmark K; Kvien TK; Olsen IC; Soldal DM; Bakland G; Lexberg Å; Gjesdal CG; Gulseth C; Haugeberg G; Semb AG
    RMD Open; 2018; 4(2):e000737. PubMed ID: 30305931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular risk profiles in a hospital-based population of patients with psoriatic arthritis and ankylosing spondylitis: a cross-sectional study.
    Nissen CB; Hørslev-Petersen K; Primdahl J
    Rheumatol Int; 2017 Jan; 37(1):113-120. PubMed ID: 27889826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory Arthritis and Heart Disease.
    Castaneda S; Gonzalez-Juanatey C; Gonzalez-Gay MA
    Curr Pharm Des; 2018; 24(3):262-280. PubMed ID: 29359662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring cardiovascular disease risk evaluation in patients with inflammatory joint diseases.
    Semb AG; Ikdahl E; Hisdal J; Olsen IC; Rollefstad S
    Int J Cardiol; 2016 Nov; 223():331-336. PubMed ID: 27543704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis.
    Peters MJ; Symmons DP; McCarey D; Dijkmans BA; Nicola P; Kvien TK; McInnes IB; Haentzschel H; Gonzalez-Gay MA; Provan S; Semb A; Sidiropoulos P; Kitas G; Smulders YM; Soubrier M; Szekanecz Z; Sattar N; Nurmohamed MT
    Ann Rheum Dis; 2010 Feb; 69(2):325-31. PubMed ID: 19773290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular risk assessment according to a national calibrated score risk index in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors.
    Rosales Alexander JL; Cantero-Hinojosa J; Salvatierra J; Magro Checa C; González-Gay MÁ; Raya Álvarez E
    Joint Bone Spine; 2014 Mar; 81(2):164-8. PubMed ID: 23932927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of rheumatologists vis-à-vis assessment of traditional cardiovascular risk factors in rheumatoid arthritis.
    Luck Y; Baron M; Bardakjian S; Berkson L; Buchignani M; Fallavolita S; Giac F; Gyger G; Tatibouet S; Hudson M
    Clin Rheumatol; 2014 Jun; 33(6):769-74. PubMed ID: 24526251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.